Votrient Tablet 400 mg
Product details
Registration number: SIN14023P
Classification: Prescription Only
Active ingredients: Pazopanib hydrochloride 433.4 mg eqv pazopanib
Strength: 400 mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: L01XE11
HSA approval date: 23 September 2011
Manufacturer(s):
- Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
- Siegfried Barbera, S.L.
- Novartis Pharmaceutical Manufacturing LLC
Manufacturing country/countries: SLOVENIA; SPAIN; UNITED KINGDOM
What are the HSA registration number and classification for Votrient Tablet 400 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14023P
Classification: Prescription Only
What active ingredients and strength are recorded for Votrient Tablet 400 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Pazopanib hydrochloride 433.4 mg eqv pazopanib
Strength: 400 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Votrient Tablet 400 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for Votrient Tablet 400 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for Votrient Tablet 400 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
- Siegfried Barbera, S.L.
- Novartis Pharmaceutical Manufacturing LLC
Manufacturing country/countries: SLOVENIA; SPAIN; UNITED KINGDOM
Where can I look up Votrient Tablet 400 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14023P or the exact product name Votrient Tablet 400 mg. The general register link does not preselect this product.
What are the source dates for this Votrient Tablet 400 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Votrient Tablet 400 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14023P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)